INOVIO PHARMACEUTICALS INC filings

SEC filings by INOVIO PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2009-02-13CONUS PARTNERS INCINOVIO BIOMEDICAL CORP1,568,9493.5%EDGAR
SC 13G/A2008-02-14Bank of New York Mellon CORPINOVIO BIOMEDICAL CORP932,3992.1%EDGAR
SC 13G/A2008-02-13CONUS PARTNERS INCINOVIO BIOMEDICAL CORP3,277,2367.2%EDGAR
SC 13G/A2007-06-11ZESIGER CAPITAL GROUP LLCINOVIO BIOMEDICAL CORP1,516,0003.4%EDGAR
SC 13G2007-03-26CONUS PARTNERS INCINOVIO BIOMEDICAL CORP2,323,2735.9%EDGAR
SC 13G/A2007-02-14CONUS PARTNERS INCINOVIO BIOMEDICAL CORP1,136,5923.2%EDGAR
SC 13G2007-02-14MELLON FINANCIAL CORPINOVIO BIOMEDICAL CORP1,935,1305.4%EDGAR
SC 13G/A2007-02-13ZESIGER CAPITAL GROUP LLCINOVIO BIOMEDICAL CORP2,247,6006.2%EDGAR
SC 13G/A2006-11-22SDS CAPITAL GROUP SPC LTDINOVIO BIOMEDICAL CORP1,792,2954.9%EDGAR
SC 13G/A2006-02-15MELLON FINANCIAL CORPINOVIO BIOMEDICAL CORP-0.0%EDGAR
SC 13G/A2006-01-10QUINTILES TRANSNATIONAL CORPINOVIO BIOMEDICAL CORP1,061,7603.5%EDGAR
SC 13G2006-01-10ZESIGER CAPITAL GROUP LLCINOVIO BIOMEDICAL CORP1,944,0006.5%EDGAR
SC 13G2006-01-09MERCK & CO INCINOVIO BIOMEDICAL CORP1,687,5005.6%EDGAR
SC 13G2006-01-05CONUS PARTNERS INCINOVIO BIOMEDICAL CORP1,546,0285.2%EDGAR
SC 13G/A2005-02-14QUINTILES TRANSNATIONAL CORPGENETRONICS BIOMEDICAL CORP954,8815.0%EDGAR
SC 13G/A2005-02-11MELLON FINANCIAL CORPGENETRONICS BIOMEDICAL CORP895,8575.0%EDGAR
SC 13G/A2005-02-11CONUS PARTNERS INCGENETRONICS BIOMEDICAL CORP940,0795.1%EDGAR
SC 13G/A2004-02-17CONUS PARTNERS INCGENETRONICS BIOMEDICAL CORP4,052,5236.9%EDGAR
SC 13G2004-02-13QUINTILES TRANSNATIONAL CORPGENETRONICS BIOMEDICAL CORP3,186,3425.1%EDGAR
SC 13G/A2004-02-04MELLON BANK N AGENETRONICS BIOMEDICAL CORP3,869,3576.6%EDGAR